
Spasmak Y 20mg/500mg Tablet
Marketer
Win-Medicare Pvt Ltd
Salt Composition
Dicyclomine (20mg) + Paracetamol (500mg)
Overview Spasmak Y 20mg/500mg Tablet
Abdominal pain relief is provided by the combined medication Spasmak Y 20 mg/500 mg Tablet. This formulation effectively eases abdominal pain and cramping by relaxing gastrointestinal muscles and inhibiting pain and fever-inducing chemical signals. Administered as directed by your physician, with or without food (though food may mitigate stomach discomfort), the dosage and treatment duration are individualized. Consistent use, as prescribed, is crucial; premature discontinuation risks symptom recurrence and potential condition worsening. Inform your doctor of all concurrent medications, as interactions are possible. Common, typically transient side effects include nausea, dry mouth, blurred vision, fatigue, and anxiety. Report any concerns promptly. Drowsiness is a potential effect; avoid driving or activities demanding concentration until its impact is known. Alcohol should be avoided due to increased drowsiness risk. Pre-treatment disclosure of liver or kidney conditions is vital for appropriate dosage determination. Breastfeeding mothers should also inform their physician.
Uses of Spasmak Y 20mg/500mg Tablet
Managing abdominal discomfort
Major Benefits of Spasmak Y 20mg/500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Spasmak Y 20 mg/500 mg Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Consumption with or without food is acceptable, although consistent timing is recommended.
Common Side effects of Spasmak Y 20mg/500mg Tablet:
- Nausea
- Dryness in mouth
- Blurred vision
- Sleepiness
- Weakness
- Nervousness
How to use Spasmak Y 20mg/500mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Spasmak Y 20 mg/500 mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
How Spasmak Y 20mg/500mg Tablet works:
Each Spasmak Y 20 mg/500 mg tablet unites dicyclomine and paracetamol to alleviate abdominal pain and cramping. The anticholinergic dicyclomine soothes gastrointestinal muscles, halting spasms and easing associated cramping, bloating, and discomfort. Paracetamol, an analgesic component, functions by inhibiting the release of pain-signaling substances.
SAFETY ADVICE
AlcoholUNSAFE
Combining Spasmak Y 20 mg/500 mg tablets with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Spasmak Y 20 mg/500 mg Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCONSULT YOUR DOCTOR
The use of Spasmak Y 20 mg/500 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Spasmak Y 20 mg/500 mg Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Spasmak Y 20 mg/500 mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Spasmak Y 20 mg/500 mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Spasmak Y 20 mg/500 mg tablets are contraindicated for individuals experiencing severe or active liver disease.
What if you forget to take Spasmak Y 20mg/500mg Tablet :
Should you forget a Spasmak Y 20 mg/500 mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Spasmak Y 20mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
